Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) Interest Expenses (2019 - 2025)

Historic Interest Expenses for Revolution Medicines (RVMD) over the last 5 years, with Q3 2025 value amounting to $11.4 million.

  • Revolution Medicines' Interest Expenses changed N/A to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 39683.16%. This contributed to the annual value of $2.5 million for FY2024, which is 73432.34% up from last year.
  • Per Revolution Medicines' latest filing, its Interest Expenses stood at $11.4 million for Q3 2025.
  • Revolution Medicines' 5-year Interest Expenses high stood at $11.4 million for Q3 2025, and its period low was $12000.0 during Q1 2021.
  • In the last 3 years, Revolution Medicines' Interest Expenses had a median value of $2.7 million in 2024 and averaged $4.2 million.
  • The largest annual percentage gain for Revolution Medicines' Interest Expenses in the last 5 years was 4285.71% (2021), contrasted with its biggest fall of 4285.71% (2021).
  • Over the past 3 years, Revolution Medicines' Interest Expenses (Quarter) stood at $12000.0 in 2021, then surged by 20966.67% to $2.5 million in 2024, then surged by 352.06% to $11.4 million in 2025.
  • Its last three reported values are $11.4 million in Q3 2025, $2.5 million for Q4 2024, and $2.8 million during Q1 2024.